Detalles de la búsqueda
1.
Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death.
Pharmacol Res
; 197: 106945, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37797662
2.
Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients.
J Formos Med Assoc
; 121(3): 643-651, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34246509
3.
CD9 Upregulation-Decreased CCL21 Secretion in Mesenchymal Stem Cells Reduces Cancer Cell Migration.
Int J Mol Sci
; 22(4)2021 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33572290
4.
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.
BMC Cancer
; 19(1): 617, 2019 Jun 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31234830
5.
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients.
Eur J Haematol
; 101(1): 86-94, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29624746
6.
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.
Ann Hematol
; 94(2): 211-21, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25241285
7.
A study of 65 patients with acquired hemophilia A in Taiwan.
J Formos Med Assoc
; 114(4): 321-7, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25839765
8.
DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications.
Blood
; 119(2): 559-68, 2012 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-22077061
9.
IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients.
Am J Hematol
; 89(9): E142-9, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24845799
10.
SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution.
Am J Hematol
; 89(8): E109-15, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24723457
11.
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics.
Blood
; 118(14): 3803-10, 2011 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-21828143
12.
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA.
Haematologica
; 103(11): e510-e513, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29773598
13.
Lineage switch of KMT2A-rearranged adult B-lineage acute lymphoblastic leukemia following bispecific T-cell engager and monoclonal antibody therapy.
J Hematop
; 16(2): 103-109, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38175441
14.
Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations.
Blood
; 116(20): 4086-94, 2010 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-20693432
15.
Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation.
Blood
; 115(14): 2749-54, 2010 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-20097881
16.
WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system.
Blood
; 115(25): 5222-31, 2010 Jun 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-20368469
17.
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission.
Bone Marrow Transplant
; 57(1): 95-105, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34671120
18.
Soluble triggering receptor expressed on myeloid cells-1 as an infection marker for patients with neutropenic fever.
Crit Care Med
; 39(5): 993-9, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21283000
19.
Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survival.
Blood
; 113(14): 3161-7, 2009 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-18988863
20.
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations.
Blood
; 114(26): 5352-61, 2009 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-19808697